Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - HAEMONETICS CORP | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - CFO CERTIFICATION - HAEMONETICS CORP | hae20150328exh322.htm |
| EX-32.1 - EXHIBIT 32.1 - CEO CERTIFICATION - HAEMONETICS CORP | hae20150328exh321.htm |
| EX-31.1 - EXHIBIT 31.1 - CEO CERTIFICATION - HAEMONETICS CORP | hae20150328exh311.htm |
| EX-21.1 - EXHIBIT 21.1 - SUBSIDIARIES OF THE COMPANY - HAEMONETICS CORP | hae20150328exh211.htm |
| EX-31.2 - EXHIBIT 31.2 - CFO CERTIFICATION - HAEMONETICS CORP | hae20150328exh312.htm |
| 10-K - FORM 10-K - HAEMONETICS CORP | hae201532810kdocument.htm |
| EX-10.AP - EXHIBIT 10.AP 2005 LONG-TERM INCENTIVE COMPENSATION PLAN PERFORMANCE SHARE UNIT - HAEMONETICS CORP | hae20150328exh10ap.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-200226, 333-181847, 333-136839, 333-149205, and 333-159434) of our reports dated May 22, 2015, with respect to the consolidated financial statements and schedule of Haemonetics Corporation and the effectiveness of internal control over financial reporting of Haemonetics Corporation, included in this Annual Report (Form 10-K) of Haemonetics Corporation for the fiscal year ended March 28, 2015.
/s/ Ernst & Young LLP
Boston, Massachusetts
May 22, 2015